140 related articles for article (PubMed ID: 2407564)
21. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
Adler G; Young D; Galant R; Quinn L; Witchger MS; Maki KC
Gynecol Obstet Invest; 2005; 59(4):212-9. PubMed ID: 15753617
[TBL] [Abstract][Full Text] [Related]
22. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.
Wiseman LR; McTavish D
Drugs Aging; 1994 Mar; 4(3):238-56. PubMed ID: 8199397
[TBL] [Abstract][Full Text] [Related]
23. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
24. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Sendağ F; Terek MC; Karadadaş N; Bilgin O
J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
[TBL] [Abstract][Full Text] [Related]
25. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
Staland B
Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
[TBL] [Abstract][Full Text] [Related]
26. Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium.
Pansini F; De Paoli D; Albertazzi P; Bonaccorsi G; Campobasso C; Zanotti L; Pisati R; Giulini NA
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):137-41. PubMed ID: 8886696
[TBL] [Abstract][Full Text] [Related]
27. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints.
Sporrong T; Hellgren M; Samsioe G; Mattsson LA
Br J Obstet Gynaecol; 1988 Oct; 95(10):1042-8. PubMed ID: 3056498
[TBL] [Abstract][Full Text] [Related]
28. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Brynhildsen J; Hammar M
Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
[TBL] [Abstract][Full Text] [Related]
29. A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
Keller PJ; Hotz E; Imthurn B
Maturitas; 1992 Dec; 15(3):195-8. PubMed ID: 1465033
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
Portman DJ; Symons JP; Wilborn W; Kempfert NJ
Am J Obstet Gynecol; 2003 Feb; 188(2):334-42. PubMed ID: 12592236
[TBL] [Abstract][Full Text] [Related]
31. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Williams SR; Frenchek B; Speroff T; Speroff L
Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827
[TBL] [Abstract][Full Text] [Related]
32. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
33. Effect on endometrium of combined oestrogen-progestogen replacement therapy of 1 mg 17beta-estradiol and 0.5 mg norethisterone acetate.
Iatrakis G; Tsionis C; Antoniadis S; Kourounis G
Clin Exp Obstet Gynecol; 2004; 31(1):50-2. PubMed ID: 14998189
[TBL] [Abstract][Full Text] [Related]
34. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
Mattsson LA; Samsioe G
Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
[TBL] [Abstract][Full Text] [Related]
35. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
[TBL] [Abstract][Full Text] [Related]
36. Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
Strandberg TE; Ylikorkala O; Tikkanen MJ
Am J Cardiol; 2003 Jul; 92(2):212-4. PubMed ID: 12860228
[No Abstract] [Full Text] [Related]
37. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J
Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905
[TBL] [Abstract][Full Text] [Related]
38. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
[TBL] [Abstract][Full Text] [Related]
39. Combined estrogen and progestogen for the menopause.
Mugglestone CJ; Swinhoe JR; Craft IL
Acta Obstet Gynecol Scand; 1980; 59(4):327-9. PubMed ID: 7004052
[TBL] [Abstract][Full Text] [Related]
40. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
